Ondansetron Injection, Solution
Product Images NDC 55154-6976

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 55154-6976). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E04be05b 6628 4245 90da E17774ffc973 00

E04be05b 6628 4245 90da E17774ffc973 00
ONDANSETRON INJECTION, USP is a sterile solution available in 5 single dose vials, each containing 4mg/2mL (2 mg/mL). It is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. This drug is not safe for children and should be kept away from them. It should be stored at controlled room temperature and protected from light until time of use. Dosage and administration instructions, precautions, and warnings can be found in the product insert. This drug is distributed by Hospira, Inc in Lake Forest, IL, USA and by Cardinal Health in Dublin, OH, USA.*
FDA Label Image

Ondansetron 01

FDA Label Image

Ondansetron 02

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.